# Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles

> **NCT00627406** · PHASE4 · COMPLETED · sponsor: **Regionshospitalet Viborg, Skive** · enrollment: 384 (actual)

## Conditions studied

- OHSS (Ovarian Hyperstimulation)

## Interventions

- **DRUG:** Buserelin and Pregnyl
- **DRUG:** Pregnyl
- **DRUG:** Buserelin and Pregnyl
- **DRUG:** Pregnyl

## Key facts

- **NCT ID:** NCT00627406
- **Lead sponsor:** Regionshospitalet Viborg, Skive
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 384 (ACTUAL)
- **Last updated:** 2013-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00627406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00627406, "Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00627406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*